93 related articles for article (PubMed ID: 6199690)
1. Methionine-enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients.
Pezzoli G; Panerai AE; Di Giulio A; Longo A; Passerini D; Carenzi A
Neurology; 1984 Apr; 34(4):516-9. PubMed ID: 6199690
[TBL] [Abstract][Full Text] [Related]
2. CSF Met-enkephalin levels in Parkinson's disease.
Sandyk R; Snider SR
Neurology; 1985 May; 35(5):776-7. PubMed ID: 3990981
[No Abstract] [Full Text] [Related]
3. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
[No Abstract] [Full Text] [Related]
4. Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease.
Growdon JH; Melamed E; Logue M; Hefti F; Wurtman RJ
Life Sci; 1982 Mar; 30(10):827-32. PubMed ID: 6175872
[TBL] [Abstract][Full Text] [Related]
5. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
6. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
7. Opposite changes in dopamine metabolites and met-enkephalin levels in the ventricular CSF of patients subjected to thalamic electrical stimulation.
Bourgoin S; Rostaing-Rigattieri S; Nguyen JP; Berberich E; Duvaldestin P; Fattaccini CM; Hamon M; Cesselin F
Clin Neuropharmacol; 1999; 22(4):231-8. PubMed ID: 10442254
[TBL] [Abstract][Full Text] [Related]
8. Failure of cerebrospinal fluid homovanillic acid to predict levodopa response in Parkinson's disease.
Weiner WJ; Klawans HL
J Neurol Neurosurg Psychiatry; 1973 Oct; 36(5):747-52. PubMed ID: 4753871
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with Parkinson's disease and its relation to dementia.
Jolkkonen J; Soininen H; Halonen T; Ylinen A; Laulumaa V; Laakso M; Riekkinen P
J Neurol Neurosurg Psychiatry; 1986 Dec; 49(12):1374-7. PubMed ID: 2433403
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptides in Parkinson's disease: effects of dopamine repletion.
Baronti F; Conant KE; Giuffra M; Davis TL; Brughitta G; Iadarola MJ; Berrettini WH; Chase TN; Mouradian MM
Brain Res; 1991 Sep; 560(1-2):92-6. PubMed ID: 1684735
[TBL] [Abstract][Full Text] [Related]
11. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
[No Abstract] [Full Text] [Related]
12. Cerebrospinal homovanillic acid and parkinsonism.
Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
[No Abstract] [Full Text] [Related]
13. [Met-enkephalin and substance P. Comparison of CSF levels in patients with chronic pain based on a sampling procedure].
Guieu R; Tardy-Gervet MF; Giraud P; Boudouresque F
Rev Neurol (Paris); 1993; 149(6-7):398-401. PubMed ID: 7508141
[TBL] [Abstract][Full Text] [Related]
14. Ventricular fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in patients with movement disorders.
Tabaddor K; Wolfson LI; Sharpless NS
Neurology; 1978 Dec; 28(12):1249-53. PubMed ID: 569783
[TBL] [Abstract][Full Text] [Related]
15. The ventricular fluid pressure and the concentration of homovanillic acid in different parts of the cerebrospinal fluid system in patients with Parkinson's disease.
West KA; Roos BE
Confin Neurol; 1972; 34(2):136-42. PubMed ID: 4579783
[No Abstract] [Full Text] [Related]
16. Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson's disease.
Ishibashi K; Kanemaru K; Saito Y; Murayama S; Oda K; Ishiwata K; Mizusawa H; Ishii K
Acta Neurol Scand; 2010 Jul; 122(1):46-51. PubMed ID: 20002007
[TBL] [Abstract][Full Text] [Related]
17. [Determination of homovanillic acid in the cerebrospinal fluid of Parkinson's disease patients and control group].
Voto Bernales J; Cruz GA; Davila E
Rev Neuropsiquiatr; 1973 Mar; 36(1):46-52. PubMed ID: 4793023
[No Abstract] [Full Text] [Related]
18. [Cerebrospinal fluid homovanillic acid in paralysis agitans and spinocerebellar degeneration (author's transl)].
Mizuno Y; Ariga T
Rinsho Shinkeigaku; 1979 Jun; 19(6):367-71. PubMed ID: 477137
[No Abstract] [Full Text] [Related]
19. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
Cramer H; Warter JM; Renaud B
Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
[No Abstract] [Full Text] [Related]
20. [The concentration of homovanillic acid and leucine-enkephalin in the lumbar CSF of patients with Parkinson's disease before and after madopar treatment].
Liu DK
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Apr; 22(2):95-8, 126-7. PubMed ID: 2791764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
